Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis

A compound having the structure of formula I:

• wherein:
• each X is independently H, halogen, alkyl, OR, SR, NR′R, or BR′R, wherein each R and each R′ is independently H, halogen, or alkyl;
• W is N;
• each A and B is optionally substituted alkyl, or A and B are joined in an optionally substituted heterocycloalkyl;
• and
• Z is an optionally present, optionally substituted 5 or 6-membered ring, saturated or unsaturated, fused to the bezotriazine ring at the 6,7 position,
• or a pharmaceutically acceptable salt or stereoisomer thereof.